|
Market Closed -
Toronto S.E.
03:59:50 2026-11-05 pm EST
|
5-day change | 1st Jan Change | ||
| 0.4050 CAD | 0.00% |
|
-1.22% | -10.99% |
| Oct. 14 | PharmaCorp Rx Appoints Andrew Hodson as New CFO | MT |
| Oct. 14 | PharmaCorp Rx Inc. Announces CFO Changes, Effective October 27, 2026 | CI |
Chart calendar PharmaCorp Rx Inc.
Upcoming events on PharmaCorp Rx Inc.
No events available
Past events on PharmaCorp Rx Inc.
| 2026-10-08 | Présentation aux Actionnaires / Analystes | 11:30 am |
| 2026-10-08 | Annual General Meeting | 11:30 am |
Annual results
| Fiscal Period | December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 | 20,9 20,5 1.92% | 50,0 | 96,0 | 85,4 |
|
EBITDA Million CAD | Released Forecast Spread | 0,00 | 3,53 2,20 60.34% | 3,99 | 10,5 | 11,2 |
|
EBIT Million CAD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 1,73 | 6,51 | 3,74 |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
Net income Million CAD | Released Forecast Spread | -1,01 | -1,48 -0,40 -270.34% | 1,50 | 6,70 | 0,00 |
|
EPS CAD | Released Forecast Spread | -0,01 | -0,01 0,00 - | 0,01 | 0,03 | 0,00 |
| Announcement Date | 22/04/25 | 29/04/26 | - |
Quarterly results
| Fiscal Period | June | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 | 2028 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 7,69 7,30 5.34% | 7,73 7,72 0.14% | 14,6 | 21,8 | 25,3 | 30,6 | 35,0 | 39,5 | ||||
|
EBITDA Million CAD | Released Forecast Spread | 1,00 | 0,18 0,71 -74.92% | 1,14 | 1,79 | 1,90 | 2,25 | 2,55 | 3,70 | 3,00 | 2,00 | ||
|
EBIT Million CAD | Released Forecast Spread | 0,08 0,05 56.85% | 0,78 | 1,19 | |||||||||
|
Net income Million CAD | Released Forecast Spread | -0,43 | -0,91 0,20 -555.85% | 0,11 | 0,03 -1,10 102.75% | 1,10 | |||||||
|
EPS CAD | Released Forecast Spread | 0,00 | -0,01 0,00 - | 0,00 | 0,00 -0,01 - | 0,00 | |||||||
| Announcement Date | 28/11/25 | 29/04/26 | 01/06/26 | 20/08/26 | - | - | - | - | - | - | - | - |
| 2026-11-11 |  | Analyst/Investor Day | |
| 2026-11-11 | | Ex-dividend date - 0.63 SAR | 12:00 am |
| 2026-11-12 | | Earnings release - Q2 2027 | P |
| 2026-11-12 | | Ex-dividend date - 0.068 EUR | 12:00 am |
| 2026-11-15 | | Extraordinary General Meeting | 09:00 pm |
| 2026-11-16 | | Extraordinary General Meeting | 01:45 am |
| 2026-11-18 | | Ex-dividend date - 0.25622 ZAR | 12:00 am |
| 2026-11-30 | | Earnings release - Q3 2026 | |
| 2026-12-11 | | Extraordinary General Meeting | 04:30 am |
| 2026-12-17 | | Ex-dividend date - 6.5 JPY | 12:00 am |
Past sector events for PharmaCorp Rx Inc.
| 2026-10-30 | | Earnings release - Q3 2026 | |
| 2026-10-30 | | Earnings release - Q3 2026 | |
| 2026-10-30 | | Extraordinary General Meeting | 05:00 am |
| 2026-10-30 | | Earnings presentation | 04:00 am |
| 2026-10-30 | | Earnings release - Q3 2026 | |
| 2026-10-29 | | Earnings release - Q3 2026 | |
| 2026-10-29 | | Earnings release - Q2 2027 | |
| 2026-10-29 | | Earnings release - Q1 2027 | P |
| 2026-10-28 | | Board of Directors Meeting | |
| 2026-10-28 | | Earnings presentation |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- PCRX Stock
- Calendar PharmaCorp Rx Inc.
Select your edition
All financial news and data tailored to specific country editions
